OBJECTIVE:To provide a reference for improvement in the quality of pharmaceutical care rendered by the prescrip-tion-checking pharmacists in the outpatient pharmacy. METHODS:The existing problems,opportunity and challenge in the pharma-ceutical care of the prescription-checking pharmacists in our hospital were analyzed on the basis of the specific requirements of new health-care reform for pharmacists’checking prescriptions,and relevant suggestions were put forward as to existing problems. RE-SULTS & CONCLUSIONS:The prescription-checking pharmacists in our hospital have problems to meet the requirements of new health-care reform for prescription-checking pharmacists due to their limited professional abilities,imperfect informatization soft-ware,less trust paid by patients to prescription-checking pharmacists and failure to rectify common off-label use through administra-tive intervention. It is suggested that the on-the-job training of the prescription-checking pharmacists be strengthened,informatiza-tion software be improved,importance be attached to the interaction among doctors,pharmacists and patients and the hospital poli-cy support be strengthened to meet the requirements of new health-care reform,embodying the pharmacists’professional value and promoting rational drug use.%目的:为提高门诊审方药师的药学服务质量提供参考。方法:结合“新医改”对药师审方的具体要求,分析我院审方药师药学服务中存在的问题、机遇和挑战;并针对存在的问题提出相关建议。结果与结论:与“新医改”对审方药师的要求比较,我院审方药师面临自身专业水平受限、信息化软件不完善、患者对审方药师信任度低、超说明书用药普遍存在而行政干预措施不给力等问题。建议通过加强审方药师的岗位培训、完善信息化软件、重视医药患互动、加强医院政策扶持等来满足“新医改”的要求,体现药师的专业价值,促进合理用药。
展开▼
机译:结合人CD20的人单克隆抗体,该抗体能够在存在补体的情况下诱导表达CD2的细胞的补体依赖性细胞毒性,并且包含根据EP1558648B1的权利要求1的轻链和重链CDR区, i),(ii)(a)和(iii)(SEQ ID Nos.16、17、18、13、14和15),特别是包含轻链和重链可变区序列的抗体根据EP1558648B1的权利要求4(SEQ ID Nos.4和2),特别是ofatumumab